Consonance Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Consonance Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,566,923	Closed	-$43.1M	–	30
2015 Q1	$43.1M	Buy	+3,566,923	New	+$33.7M	3.93%	12
2014 Q3	–	Sell	-1,440,008	Closed	-$15.8M	–	29
2014 Q2	$15.8M	Buy	+1,440,008	New	+$12.8M	2.35%	18

Other funds holding SUPN

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return